Gilead Sciences, Inc.
2013 Q4 - 2025 Q4 (28 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 198,054 | 0.4% | 1,613,608 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 176,919 | 0.4% | 1,593,867 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 175,638 | 0.4% | 1,584,182 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 170,241 | 0.5% | 1,519,333 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 130,397 | 0.4% | 1,411,679 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 71,116 | 0.2% | 848,235 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 53,116 | 0.2% | 774,172 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 87,047 | 0.3% | 1,188,361 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 120,806 | 0.5% | 1,491,253 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 106,222 | 0.5% | 1,417,429 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 111,189 | 0.5% | 1,442,700 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 71,923 | 0.4% | 866,858 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 70,964 | 0.4% | 826,610 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 46,329 | 0.3% | 751,004 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 45,637 | 0.3% | 738,338 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 46,808 | 0.2% | 787,351 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 52,980 | 0.3% | 729,653 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 48,282 | 0.3% | 691,222 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 44,248 | 0.2% | 642,572 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 38,244 | 0.2% | 591,745 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 39,496 | 0.2% | 677,925 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 40,074 | 0.3% | 634,185 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 45,983 | 0.4% | 597,653 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 44,117 | 0.4% | 590,111 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 37,872 | 0.3% | 582,825 | 12/31/2019 |
| 2014 Q2 | 8/6/2014 | 32,781 | 1.0% | 395,378 | 6/30/2014 |
| 2014 Q1 | 4/29/2014 | 29,545 | 0.9% | 416,955 | 3/31/2014 |
| 2013 Q4 | 2/3/2014 | 29,011 | 0.9% | 386,048 | 12/31/2013 |